SE434701B - Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa - Google Patents

Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa

Info

Publication number
SE434701B
SE434701B SE7601841A SE7601841A SE434701B SE 434701 B SE434701 B SE 434701B SE 7601841 A SE7601841 A SE 7601841A SE 7601841 A SE7601841 A SE 7601841A SE 434701 B SE434701 B SE 434701B
Authority
SE
Sweden
Prior art keywords
interferon
pseudomonas aeruginosa
infection prevention
make tumor
inducing bacteria
Prior art date
Application number
SE7601841A
Other languages
English (en)
Swedish (sv)
Other versions
SE7601841L (sv
Inventor
Y Homma
C Abe
K Tanamoto
K Kuretani
A Hoshi
Original Assignee
Univ Tokyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tokyo filed Critical Univ Tokyo
Publication of SE7601841L publication Critical patent/SE7601841L/xx
Publication of SE434701B publication Critical patent/SE434701B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/874—Pseudomonas
    • Y10S435/875—Pseudomonas aeruginosa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
SE7601841A 1975-05-14 1976-02-18 Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa SE434701B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50055979A JPS51133489A (en) 1975-05-14 1975-05-14 Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities

Publications (2)

Publication Number Publication Date
SE7601841L SE7601841L (sv) 1976-11-15
SE434701B true SE434701B (sv) 1984-08-13

Family

ID=13014183

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7601841A SE434701B (sv) 1975-05-14 1976-02-18 Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa

Country Status (7)

Country Link
US (1) US4079126A (de)
JP (1) JPS51133489A (de)
CA (1) CA1060797A (de)
DE (1) DE2610504C2 (de)
FR (1) FR2311093A1 (de)
GB (1) GB1537509A (de)
SE (1) SE434701B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5296729A (en) * 1976-02-05 1977-08-13 Shionogi & Co Ltd Mixed vaccin for cyanomycosis
CA1085293A (en) * 1976-02-05 1980-09-09 Yuzuru Homma Toxoids derived from protease and elastase of pseudomonas aeruginosa and production thereof
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
CA1256370A (en) * 1984-02-24 1989-06-27 Yuzuru Homma Toxoids of elastase of pseudomonas aeruginosa origin
AT384032B (de) * 1985-01-14 1987-09-25 Immuno Ag Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
US5179001A (en) * 1985-09-27 1993-01-12 The Regents Of The University Of California Detection and monitoring of chronic and gram-negative infection
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
FR2613380B1 (fr) * 1987-04-06 1989-11-17 Pasteur Institut Nouvelle substance adjuvante de certains antimitotiques chimiques, procede d'obtention de cette substance a partir de cultures de vibrio cholerae, agents therapeutiques contenant ladite substance
CA2071478A1 (en) * 1989-10-27 1991-04-28 Jeffery A. Bluestone Methods and compositions for promoting immunopotentiation
US6406696B1 (en) 1989-10-27 2002-06-18 Tolerance Therapeutics, Inc. Methods of stimulating the immune system with anti-CD3 antibodies
US20030108548A1 (en) * 1993-06-01 2003-06-12 Bluestone Jeffrey A. Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
US6491916B1 (en) 1994-06-01 2002-12-10 Tolerance Therapeutics, Inc. Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
CA2614640A1 (en) * 2005-07-11 2007-01-18 Macrogenics, Inc. Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
SG177907A1 (en) * 2006-06-14 2012-02-28 Macrogenics Inc Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
WO2008079713A2 (en) * 2006-12-21 2008-07-03 Macrogenics Inc. Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity
JP6253991B2 (ja) * 2011-03-02 2017-12-27 ジェローム シェンターク， 肝臓脂肪症単独又はｃ型肝炎ウイルス感染を伴った肝臓脂肪症の治療のための組成物、治療法及び診断法
CN109401992B (zh) * 2017-08-18 2021-07-23 黑龙江省科学院微生物研究所 一株高产内毒素蛋白的铜绿假单胞菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS496096B1 (de) * 1970-09-30 1974-02-12
CA993357A (en) * 1970-10-20 1976-07-20 Eisai Co. Ltd. Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-injection properties
FR2184531B1 (de) * 1972-05-19 1975-10-17 Anvar

Also Published As

Publication number Publication date
GB1537509A (en) 1978-12-29
SE7601841L (sv) 1976-11-15
CA1060797A (en) 1979-08-21
FR2311093B1 (de) 1979-06-29
JPS6123167B2 (de) 1986-06-04
DE2610504A1 (de) 1976-11-25
US4079126A (en) 1978-03-14
DE2610504C2 (de) 1985-07-11
JPS51133489A (en) 1976-11-19
FR2311093A1 (fr) 1976-12-10

Similar Documents

Publication Publication Date Title
SE434701B (sv) Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa
SE7610788L (sv) Zeolit nu-1 och sett att framstella densamma
SE7611646L (sv) Grundmassa och sett att framstella densamma
SE7602339L (sv) Kinolonderivat och sett att framstella desamma
SE414268B (sv) Muskelskelettknestodmuff och sett att framstella densamma
SE427527B (sv) Rorformigt filterelement och sett att framstella det
SE411766B (sv) Herdbar komposition och sett att framstella densamma
SE424181B (sv) Sett att framstella kulformiga aliminiumoxid- innehallande partiklar
SE7806122L (sv) Kontaktlins och sett att framstella densamma
SE7601238L (sv) Sett att behandla avlutar
SE7606265L (sv) Panel och sett att framstella densamma
SE7607240L (sv) Sett att framstella pyrrolettiksyraforeningar
FR2299761A1 (fr) Montage d'amplificateur differentiel cmos utilis
SE7805269L (sv) Azolyleterderivat till anvendning som fungicider och sett att framstella foreningarna
SE7607004L (sv) Klisterremsa och sett att tillverka denna
SE421185B (sv) Sett att framstella plastror med muff och plastror framstellt enligt settet
SE421695B (sv) Sett att framstella piperazinylpyraziner
SE412488B (sv) Halvledarkomponentbricka och sett att framstella densamma
FR2311210A1 (fr) Dispositif d'assemblage de deux pieces de bois
SE7608887L (sv) Foreningar av cefalosporin-typ och sett att framstella desamma
SE7605650L (sv) Diskmaskin och sett for att driva densamma
SE408649B (sv) Viskositetsreglerade pigmentkoncentrat och sett att framstella koncentraten
SE7601927L (sv) Nya isocyanater och sett att framstella dessa
SE427559B (sv) Sett att frastella 1-n-(alfa-substituerade-omega-aminoacyl)-3'-deoxiribostamyciner
SE7614107L (sv) Depa-steroidestrar och sett att framstella desamma